ArticleDrug design, development and therapy2024

Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway.

Min Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.